Sign In | 0 items - USD $0.00 | Search | 简体中文

Products Content

Blog Tag: Parkinson's disease

Podcast: Gene Expression in Parkinson’s Disease with Alessia Sciortino

Patricia Thomson | September 23rd, 2020 | Podcasts

Parkinson's Disease Therapies Targeting Alpha Synuclein

Parkinson’s Disease Therapies Targeting Alpha Synuclein

Christina Korgiopoulou | September 9th, 2020 | Scientific Review

Types of Alpha Synuclein Fibrillar Constructs

Types of Alpha Synuclein Fibrillar Constructs

Christina Korgiopoulou | August 10th, 2020 | Scientific Review

Alpha synuclein oligomers and their role in synucleinopathies

Alpha Synuclein Oligomers and their Role in Synucleinopathies

Christina Korgiopoulou | July 22nd, 2020 | Scientific Review

FTY720/Fingolimod: A Potential Parkinson's Disease Treatment

FTY720/Fingolimod: A Potential Parkinson’s Disease Treatment

Christina Korgiopoulou | June 30th, 2020 | Scientific Review

Parkinson's Disease Models An Overview of Cellular Models for Neurodegeneration

Parkinson’s Disease Models: An Overview of Cellular and Animal Models for Neurodegeneration Research

Christina Korgiopoulou | January 29th, 2020 | Scientific Review

Alpha Synuclein in Parkinson's Disease

Alpha Synuclein in Parkinson’s Disease

Christina Korgiopoulou | January 22nd, 2020 | Scientific Review

VPS35 in Parkinson's Disease

VPS35 in Parkinson’s Disease

Christina Korgiopoulou | December 17th, 2019 | Scientific Review

Dopamine Alpha Synuclein Oligomers

Alpha Synuclein Oligomers: Dopamine Stabilization and Neurodegeneration

Patricia Thomson | August 21st, 2019 | Scientific Review

A53T Alpha Synuclein in Parkinson's Disease

A53T Alpha Synuclein in Parkinson’s Disease

Patricia Thomson | February 12th, 2019 | Scientific Review